Marker Therapeutics (MRKR) Amortization of Deferred Charges (2014 - 2015)
Marker Therapeutics (MRKR) reported Amortization of Deferred Charges of -$8.3 million for Q2 2015, down 23508.66% quarter-over-quarter from $35269.0 in Q1 2014.
Marker Therapeutics (MRKR) Amortization of Deferred Charges (2014 - 2015) Analysis & Trends
Marker Therapeutics (MRKR) has 2 years of Amortization of Deferred Charges data on file, last reported at -$8.3 million in Q2 2015.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Alterity Therapeutics | 788,338.31 Bn | 788,338.28 Bn | - |
| 2 | Belite Bio | 56,560.00 Bn | 56,560.00 Bn | - |
| 3 | Quantum Biopharma | 17,329.30 Bn | 17,329.30 Bn | - |
| 4 | Legend Biotech | 3,341.00 Bn | 3,340.71 Bn | 242.10 Mn |
| 5 | Akari Therapeutics | 1,727.91 Bn | 1,727.91 Bn | - |
| 6 | Evaxion A | 1,536.68 Bn | 1,536.67 Bn | - |
| 7 | Psyence Biomedical | 238.34 Bn | 238.33 Bn | - |
| 8 | Vertex Pharmaceuticals | 113.42 Bn | 106.17 Bn | 2.59 Bn |
| 9 | Abivax | 95.45 Bn | 95.45 Bn | - |
| 10 | Marker Therapeutics | 27.04 Mn | 27.04 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2015 | -8.26 Mn |
| Jun 30, 2015 | -8.26 Mn |
| Mar 31, 2014 | 35,269.00 |
| Mar 31, 2014 | 35,269.00 |